Fig. 3From: Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for P-cadherin targeted therapy: a retrospective cohort studyDifferences in P-cadherin scores were compared among histologic subtypes. The P-cadherin score was assessed by the sum of the Intensity Score (IS) and Positive Percentage Score (PPS) in primary tumors of 162 patients. *P < 0 .01Back to article page